Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Platelets mediate cytotoxic T lymphocyte–induced liver damage

Nature Medicine volume 11, pages 1167–1169 (2005)Cite this article

Abstract

We found that platelet depletion reduces intrahepatic accumulation of virus-specific cytotoxic T lymphocytes (CTLs) and organ damage in mouse models of acute viral hepatitis. Transfusion of normal but not activation-blocked platelets in platelet-depleted mice restored accumulation of CTLs and severity of disease. In contrast, anticoagulant treatment that prevented intrahepatic fibrin deposition without reducing platelet counts did not avert liver injury. Thus, activated platelets contribute to CTL-mediated liver immunopathology independently of procoagulant function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Activated platelets enhance intrahepatic accumulation of CTLs and severity of liver disease in HBV transgenic mice independently of fibrin deposition.
Figure 2: Platelet depletion ameliorates liver disease in adenovirus-infected mice and reduces the intrahepatic accumulation of virus-specific CTLs.

Similar content being viewed by others

References

  1. Guidotti, L.G. & Chisari, F.V. Annu. Rev. Immunol. 19, 65–91 (2001).

    Article  CAS  Google Scholar 

  2. Wilson, J.M. Adv. Drug Deliv. Rev. 46, 205–209 (2001).

    Article  CAS  Google Scholar 

  3. Weyrich, A.S., Lindemann, S. & Zimmerman, G.A. J. Thromb. Haemost. 1, 1897–1905 (2003).

    Article  CAS  Google Scholar 

  4. Weyrich, A.S. & Zimmerman, G.A. Trends Immunol. 25, 489–495 (2004).

    Article  CAS  Google Scholar 

  5. Ando, K. et al. J. Immunol. 152, 3245–3253 (1994).

    CAS  PubMed  Google Scholar 

  6. Guidotti, L.G. et al. Immunity 4, 25–36 (1996).

    Article  CAS  Google Scholar 

  7. Kakimi, K. et al. J. Exp. Med. 194, 1755–1766 (2001).

    Article  CAS  Google Scholar 

  8. Sitia, G. et al. J. Clin. Invest. 113, 1158–1167 (2004).

    Article  CAS  Google Scholar 

  9. McClary, H., Koch, R., Chisari, F.V. & Guidotti, L.G. J. Virol. 74, 2255–2264 (2000).

    Article  CAS  Google Scholar 

  10. Ware, J., Russell, S. & Ruggeri, Z.M. Proc. Natl. Acad. Sci. USA 97, 2803–2808 (2000).

    Article  CAS  Google Scholar 

  11. Chisari, F.V. & Ferrari, C. Annu. Rev. Immunol. 13, 29–60 (1995).

    Article  CAS  Google Scholar 

  12. Shoukry, N.H., Cawthon, A.G. & Walker, C.M. Annu. Rev. Microbiol. 58, 391–424 (2004).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to S. Wieland for providing the pCMV-lacZ plasmid and for discussions. We also thank S. Medrano and M. Chadwell for technical assistance. This work was supported by US National Institutes of Health grants HL31950, HL42846, HL78784 (to Z.M.R.), CA40489 (to F.V.C.) and AI40696 (to L.G.G.). Work in the Board of Governors Gene Therapy Research Institute is funded by the Board of Governors at Cedars-Sinai Medical Center, the US National Institutes of Health and the Bram and Elaine Goldsmith Chair in Gene Therapeutics. This is manuscript number 16807-MEM from the Scripps Research Institute.

Author information

Authors and Affiliations

  1. Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, 92037, California, USA

    Matteo Iannacone, Masanori Isogawa, Patrizia Marchese, Francis V Chisari, Zaverio M Ruggeri & Luca G Guidotti

  2. Immunopathogenesis of Liver Infections Unit, San Raffaele Scientific Institute, Via Olgettina 58, Milan, 20132, Italy

    Matteo Iannacone, Giovanni Sitia & Luca G Guidotti

  3. Board of Governors Gene Therapeutics Research Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, 90048, California, USA

    Maria G Castro & Pedro R Lowenstein

  4. Department of Molecular and Medical Pharmacology, University of California at Los Angeles, Box 951735, 23-138 CHS, Los Angeles, 90095, California, USA

    Maria G Castro & Pedro R Lowenstein

Authors
  1. Matteo Iannacone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giovanni Sitia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masanori Isogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrizia Marchese
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria G Castro
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pedro R Lowenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Francis V Chisari
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Zaverio M Ruggeri
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Luca G Guidotti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luca G Guidotti.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

Platelets accumulate within necroinflammatory foci of the liver. (PDF 2379 kb)

Supplementary Fig. 2

Reduced levels of IFN-γ expression and inhibition of viral replication reflect the homing of fewer but functional CTLs in the liver of thrombocytopenic HBV transgenic mice. (PDF 412 kb)

Supplementary Fig. 3

TKK-PLTs are recognized by α-PLT both in vitro and in vivo. (PDF 845 kb)

Supplementary Fig. 4

Restoration of liver disease severity, CTL accumulation and intrahepatic IFN-γ expression in platelet-depleted mice upon TKK-PLT transfusion. (PDF 727 kb)

Supplementary Fig. 5

Platelet-dependent fibrin deposition within the inflamed liver. (PDF 2428 kb)

Supplementary Table 1

α-PLT treatment selectively depletes platelets in vivo. (PDF 20 kb)

Supplementary Video 1

CTLs interact with activated platelets in vitro. (MOV 41155 kb)

Supplementary Methods (PDF 65 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iannacone, M., Sitia, G., Isogawa, M. et al. Platelets mediate cytotoxic T lymphocyte–induced liver damage. Nat Med 11, 1167–1169 (2005). https://doi.org/10.1038/nm1317

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1317

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing